Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-15.00%
↓ 212% below average
Average (9y)
13.34%
Historical baseline
Range
High:56.10%
Low:-27.93%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -15.00% |
| 2023 | 20.63% |
| 2022 | 56.10% |
| 2021 | 35.65% |
| 2020 | -4.94% |
| 2019 | -6.52% |
| 2018 | 26.79% |
| 2017 | -27.93% |
| 2016 | 20.22% |
| 2015 | 28.42% |